Gyre Therapeutics, Inc. GYRE All Other Segments — Operating Income
Other segment segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Gyre Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:OperatingIncomeLoss.
The official record: Gyre Therapeutics, Inc.’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →
Ask your AI about Gyre Therapeutics, Inc.'s all other segments — operating income.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Gyre Therapeutics, Inc.'s all other segments — operating income?
- Gyre Therapeutics, Inc. (GYRE) reported all other segments — operating income of -$6K in Q1 2026.
- How has Gyre Therapeutics, Inc.'s all other segments — operating income changed year-over-year?
- Gyre Therapeutics, Inc.'s all other segments — operating income decreased by 100.0% year-over-year, from -$3K to -$6K.
- What is the long-term trend for Gyre Therapeutics, Inc.'s all other segments — operating income?
- Over 2 years (2022 to 2025), Gyre Therapeutics, Inc.'s all other segments — operating income has grown at a -61.8% compound annual growth rate (CAGR), from -$130K to -$19K.
- What does all other segments — operating income mean?
- This metric represents the profit or loss generated by the 'All Other Segments' business unit after deducting operating expenses from its revenue. It is a primary indicator of the operational health and financial viability of these non-core business activities. A positive value indicates operational profitability, while a negative value indicates an operating loss.